Biana Godin

Summary

Affiliation: Baylor College of Medicine
Country: USA

Publications

  1. ncbi Tailoring the degradation kinetics of mesoporous silicon structures through PEGylation
    Biana Godin
    Department of Nanomedicine and BioMedical Engineering, School of Medicine, University of Texas Health Science Center at Houston, Houston, Texas 77030, USA
    J Biomed Mater Res A 94:1236-43. 2010
  2. ncbi Mitotic trafficking of silicon microparticles
    Rita E Serda
    University of Texas Health Science Center, Department of Nanomedicine and BioMedical Engineering, 1825 Pressler, Suite 537, Houston, TX 77030, USA
    Nanoscale 1:250-9. 2009
  3. ncbi Near-infrared imaging method for the in vivo assessment of the biodistribution of nanoporous silicon particles
    Ennio Tasciotti
    Department of Nanomedicine, The Methodist Hospital Research Institute, Houston, TX 77030, USA
    Mol Imaging 10:56-68. 2011
  4. ncbi Drug delivery: Logic-Embedded Vectors for Intracellular Partitioning, Endosomal Escape, and Exocytosis of Nanoparticles (Small 23/2010)
    Rita E Serda
    Department of Nanomedicine and BioMedical Engineering, University of Texas Health Science Center, 1825 Pressler Street, Suite 537, Houston, TX 77030, USA
    Small 6:2690. 2010
  5. ncbi Multistage nanovectors: from concept to novel imaging contrast agents and therapeutics
    Biana Godin
    Department of Nanomedicine, The Methodist Hospital Research Institute, Houston, Texas 77030, USA
    Acc Chem Res 44:979-89. 2011
  6. ncbi Multi-stage delivery nano-particle systems for therapeutic applications
    Rita E Serda
    University of Texas Health Science Center, Department of Nanomedicine and BioMedical Engineering, 1825 Pressler, Suite 537, Houston, TX 77030, USA
    Biochim Biophys Acta 1810:317-29. 2011
  7. ncbi Enabling individualized therapy through nanotechnology
    Jason H Sakamoto
    The University of Texas Health Science Center, Department of Nanomedicine and BioMedical Engineering, Houston, TX 77030, USA
    Pharmacol Res 62:57-89. 2010
  8. ncbi Cellular association and assembly of a multistage delivery system
    Rita E Serda
    Department of Nanomedicine and BioMedical Engineering, University of Texas Health Science Center UTHSC, Houston, TX 77030, USA
    Small 6:1329-40. 2010
  9. ncbi Logic-embedded vectors for intracellular partitioning, endosomal escape, and exocytosis of nanoparticles
    Rita E Serda
    Department of Nanomedicine and BioMedical Engineering, University of Texas Health Science Center, 1825 Pressler Street, Suite 537, Houston, TX 77030, USA
    Small 6:2691-700. 2010
  10. ncbi Size of the nanovectors determines the transplacental passage in pregnancy: study in rats
    Jerrie S Refuerzo
    Department of Obstetrics, Gynecology, and Reproductive Medicine, University of Texas Health Science Center at Houston, 77030, USA
    Am J Obstet Gynecol 204:546.e5-9. 2011

Collaborators

Detail Information

Publications14

  1. ncbi Tailoring the degradation kinetics of mesoporous silicon structures through PEGylation
    Biana Godin
    Department of Nanomedicine and BioMedical Engineering, School of Medicine, University of Texas Health Science Center at Houston, Houston, Texas 77030, USA
    J Biomed Mater Res A 94:1236-43. 2010
    ....
  2. ncbi Mitotic trafficking of silicon microparticles
    Rita E Serda
    University of Texas Health Science Center, Department of Nanomedicine and BioMedical Engineering, 1825 Pressler, Suite 537, Houston, TX 77030, USA
    Nanoscale 1:250-9. 2009
    ..The finding that mitotic sorting of endosomes is unencumbered by the presence of nanoporous silicon microparticles advocates the use of silicon microparticles for biomedical applications...
  3. ncbi Near-infrared imaging method for the in vivo assessment of the biodistribution of nanoporous silicon particles
    Ennio Tasciotti
    Department of Nanomedicine, The Methodist Hospital Research Institute, Houston, TX 77030, USA
    Mol Imaging 10:56-68. 2011
    ....
  4. ncbi Drug delivery: Logic-Embedded Vectors for Intracellular Partitioning, Endosomal Escape, and Exocytosis of Nanoparticles (Small 23/2010)
    Rita E Serda
    Department of Nanomedicine and BioMedical Engineering, University of Texas Health Science Center, 1825 Pressler Street, Suite 537, Houston, TX 77030, USA
    Small 6:2690. 2010
    ..Thus, LEVs provide a mechanism for shielded transport of nanoparticles to the lesion, cellular manipulation at multiple levels, and a means for targeting both within and between cells...
  5. ncbi Multistage nanovectors: from concept to novel imaging contrast agents and therapeutics
    Biana Godin
    Department of Nanomedicine, The Methodist Hospital Research Institute, Houston, Texas 77030, USA
    Acc Chem Res 44:979-89. 2011
    ..We envision that the versatility of the MSV platform and its emerging properties will enable the creation of personalized solutions with broad clinical implications within and beyond the realm of cancer theranostics...
  6. ncbi Multi-stage delivery nano-particle systems for therapeutic applications
    Rita E Serda
    University of Texas Health Science Center, Department of Nanomedicine and BioMedical Engineering, 1825 Pressler, Suite 537, Houston, TX 77030, USA
    Biochim Biophys Acta 1810:317-29. 2011
    ..The progressive evolution of nanovectors has led to the development of multi-stage delivery systems aimed at overcoming the numerous obstacles encountered by nanovectors on their journey to the target site...
  7. ncbi Enabling individualized therapy through nanotechnology
    Jason H Sakamoto
    The University of Texas Health Science Center, Department of Nanomedicine and BioMedical Engineering, Houston, TX 77030, USA
    Pharmacol Res 62:57-89. 2010
    ....
  8. ncbi Cellular association and assembly of a multistage delivery system
    Rita E Serda
    Department of Nanomedicine and BioMedical Engineering, University of Texas Health Science Center UTHSC, Houston, TX 77030, USA
    Small 6:1329-40. 2010
    ..This study demonstrates the assembly and cellular association of a multiparticle delivery system that is biomolecularly targeted and has potential for applications in biological imaging...
  9. ncbi Logic-embedded vectors for intracellular partitioning, endosomal escape, and exocytosis of nanoparticles
    Rita E Serda
    Department of Nanomedicine and BioMedical Engineering, University of Texas Health Science Center, 1825 Pressler Street, Suite 537, Houston, TX 77030, USA
    Small 6:2691-700. 2010
    ..Thus, LEVs provide a mechanism for shielded transport of nanoparticles to the lesion, cellular manipulation at multiple levels, and a means for targeting both within and between cells...
  10. ncbi Size of the nanovectors determines the transplacental passage in pregnancy: study in rats
    Jerrie S Refuerzo
    Department of Obstetrics, Gynecology, and Reproductive Medicine, University of Texas Health Science Center at Houston, 77030, USA
    Am J Obstet Gynecol 204:546.e5-9. 2011
    ..The objective of the study was to examine whether the size of silicon nanovectors (SNVs) inhibits their entrance into the fetal circulation...
  11. ncbi An integrated approach for the rational design of nanovectors for biomedical imaging and therapy
    Biana Godin
    Department of Nanomedicine and BioMedical Engineering, The University of Texas Health Science Center, Houston, Texas, USA
    Adv Genet 69:31-64. 2010
    ....
  12. ncbi Geometrical confinement of gadolinium-based contrast agents in nanoporous particles enhances T1 contrast
    Jeyarama S Ananta
    Department of Chemistry, Smalley Institute for Nanoscale Science and Technology, Center for Biological and Environmental Nanotechnology, Rice University, Houston, Texas 77251 1892, USA
    Nat Nanotechnol 5:815-21. 2010
    ..Thus, nanoscale confinement offers a new and general strategy for enhancing the contrast of gadolinium-based contrast agents...
  13. ncbi Sustained small interfering RNA delivery by mesoporous silicon particles
    Takemi Tanaka
    Department of Nanomedicine and BioMedical Engineering, University of Texas Health Science Center at Houston, Texas, USA
    Cancer Res 70:3687-96. 2010
    ..In summary, we have provided the first in vivo therapeutic validation of a novel, multistage siRNA delivery system for sustained gene silencing with broad applicability to pathologies beyond ovarian neoplasms...
  14. ncbi Emerging applications of nanomedicine for the diagnosis and treatment of cardiovascular diseases
    Biana Godin
    Department of Nanomedicine and BioMedical Engineering, The University of Texas Health Science Center at Houston, 1825 Pressler, Suite 537, Houston, TX 77030, USA
    Trends Pharmacol Sci 31:199-205. 2010
    ..Specifically, we discuss the use of nanoparticles for molecular imaging and advanced therapeutics, specially designed drug eluting stents and in vivo/ex vivo early detection techniques...